In conclusion, our study describes for the first time that patients with T2D present increased serum osteoglycin levels compared with nondiabetic controls, although we found no evidence to support a relevant role for this protein in the development of atherosclerosis in this population. This evidence concerns the gene OGN and type 2 diabetes mellitus.